![]() | Up a level |
Ware, KE and Thomas, BC and Olawuni, PD and Sheth, MU and Hawkey, N and Yeshwanth, M and Miller, BC and Vietor, KJ and Jolly, MK and Kim, SY and Armstrong, AJ and Somarelli, JA (2023) A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer. In: Frontiers in Molecular Biosciences, 10 .
Jindal, R and Nanda, A and Pillai, M and Ware, KE and Singh, D and Sehgal, M and Armstrong, AJ and Somarelli, JA and Jolly, MK (2023) Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer. In: Computational and Structural Biotechnology Journal, 21 . 1498 – 1509.
Somarelli, JA and Armstrong, AJ and Sheth, MU and Ware, KE and Jolly, MK (2020) Phenotypic plasticity and lineage switching in prostate cancer. [Book Chapter]
Jolly, MK and Ware, KE and Xu, S and Gilja, S and Shetler, S and Yang, Y and Wang, X and Austin, RG and Runyambo, D and Hish, AJ and DeWitt, SB and George, JT and Kreulen, RT and Boss, M-K and Lazarides, AL and Kerr, DL and Gerber, DG and Sivaraj, D and Armstrong, AJ and Dewhirst, MW and Eward, WC and Levine, H and Somarelli, JA (2019) E-cadherin represses anchorage-independent growth in sarcomas through both signaling and mechanical mechanisms. In: Molecular Cancer Research, 17 (6). pp. 1391-1402.
Xu, S and Ware, KE and Ding, Y and Kim, SY and Sheth, MU and Rao, S and Chan, W and Armstrong, AJ and Eward, WC and Jolly, MK and Somarelli, JA (2019) An integrative systems biology and experimental approach identifies convergence of epithelial plasticity, metabolism, and autophagy to promote chemoresistance. In: Journal of Clinical Medicine, 8 (2).